Guidelines of the Polish Society of Ophthalmology for the treatment of exudative age-related macular degeneration
Klinika Oczna, ISSN: 0023-2157, Vol: 123, Issue: 2, Page: 53-59
2021
- 2Citations
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
Article Description
Age-related macular degeneration (AMD) is the most common cause of severe visual impairment in older adults in the developed world. Especially neovascular AMD, characterized by rapid progression and a significant reduction in visual acuity, until recently was a therapeutic challenge. The last 15 years have been a period of development of new diagnostic and treatment possibilities. The paper presents recommendations of the Polish Ophthalmological Society for the management of neovascular age-related macular degeneration based on the latest publications.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85113816691&origin=inward; http://dx.doi.org/10.5114/ko.2021.107766; https://www.termedia.pl/doi/10.5114/ko.2021.107766; https://www.termedia.pl/doi_ft/10.5114/ko.2021.107766; https://dx.doi.org/10.5114/ko.2021.107766; https://www.klinikaoczna.pl/Guidelines-of-the-Polish-Society-of-Ophthalmology-for-the-treatment-of-exudative-age-related-macular-degeneration,124,44694,0,1.html
Termedia Sp. z.o.o.
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know